Patent · US Active

Methods and reagents for treating diabetes

US11707490B2 · kind B2 · utility

0Cited by

6References

20Claims

0Family size

Assignee

BIOCRINE AB · SE

Inventor

Per-Olof Berggren · Solna, SE

Key dates

Filing date	Jul 16, 2019
Grant date	Jul 25, 2023
Priority date	—
Expiry date	Jan 16, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/10343
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are methods for treating or limiting development of diabetes, by transplanting into the eye of a subject with diabetes or at risk of diabetes an amount effective to treat or limit development of diabetes of insulin-producing cells engineered to reduce expression of a β3 subunit of Cav (Cavβ3).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.